/ /

  • linkedin
  • Increase Font
  • Sharebar

    2016 Resident Writer's Award Winner: 10 tips for TEN

    Treating OSD associated with toxic epidermal necrolysis


    Summary and conclusions

    Ten key points in the management of TEN:

    1. SJS/TEN is a severe life-threatening inflammatory reaction associated with common medications such as sulfa drugs, which should be discontinued.

    2. The overall risk of mortality with SJS/TEN is 20-25%.

    3. Up to 80% patients with SJS/TEN have ocular involvement.

    4. Urgent ophthalmologic assessment is necessary.

    5. Acute ocular involvement may be mild with only conjunctivitis, but can progress rapidly to include corneal and conjunctival defects.

    6. Early use of topical corticosteroids and antibiotics is recommended.

    7. Treatment with systemic corticosteroids and IVIG is controversial and has not been shown to improve ocular outcomes.

    8. Corneal and conjunctival epithelial sloughing should be treated with amniotic membrane grafts, including use of rings or sutured placement.

    9. Long-term complications include scarring, symblephara, dry eye, and trichiasis, which can lead to severe discomfort and ultimately blindness.

    10. Close follow-up and treatment of acute ocular involvement can prevent long-term visual loss.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results